Clinical trial · Interventional
Adenoma Detection Rate in Colonoscopy Performed With EndoRings
Adenoma Detection Rate in Colonoscopy Performed With EndoRings - a Single-centre Prospective Randomised Clinical Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Practically difficult to inroll the number of patients anticipated
Summary
Brief summary (as posted)
The study is designed to examine whether colonoscopy using an EndoRings cap has a higher adenoma detection rate than conventional colonoscopy. Secondary end-points is to compare completion rate, completion time, complication rate and detection of malignancies. Half of the patients will be randomised to colonoscopy using cap and the other half to no cap.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Adenoma | Colorectal Adenoma | ONTOLOGY_EXACT | 0.98 |
| Colorectal Neoplasms | Colorectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EndoRings II Distal Attachment | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- With EndoRings
- description
- Colonoscopy is performed with the use of the cap-device EndoRings II Distal Attachment to be attached to the tip of the colonoscope
- interventionNames
- Device: EndoRings II Distal Attachment
- type
- NO_INTERVENTION
- label
- NO EndoRings
- description
- Colonoscopy is performed conventionally without any caps
Primary outcomes (1)
- measure
- Adenoma detection rate
- timeFrame
- maximum 60 minutes
- description
- Number of colorectal adenomas/neoplasms/carcinomas found in colonoscopy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: Patients meeting all the below listed criteria are eligible for inclusion in the trial: 1. Age between 50 - 74 years (age range of screening population) 2. Positive HemoCult home test from the Danish Colorectal Cancer Screening Programme 3. Ability to give informed consent to participation in the trial. Exclusion Criteria: Patients meeting one or more of the below listed criteria will be excluded from the trial: 1. History of colorectal cancer 2. History of Inflammatory Bowel Disease 3. Part of other control programme (e.g. HNPCC or adenoma control) 4. ASA =/\> 4 and/or necessity of general anaesthesia 5. Former surgery with removal of a part of the colon on either benign or malignant background
References
Publications (0)
Data not yet available